Evolution and Clinical Significance of the T Cell Proliferative and Cytokine Response Directed Against the Fibronectin Binding Antigen 85 Complex of Bacillus Calmette-Guerin During Intravesical Treatment of Superficial Bladder Cancer
- 1 February 1997
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 157 (2) , 492-498
- https://doi.org/10.1016/s0022-5347(01)65185-1
Abstract
The antitumorigenic effect of intravesical bacillus Calmette-Guerin (BCG) in superficial bladder cancer was reported to be initiated by the attachment of BCG to the bladder wall via fibronectin. The antigen 85 complex secreted in BCG culture filtrate binds specifically to fibronectin and is a powerful T cell stimulus. Therefore, we investigated the evolution and clinical significance of the cellular proliferative response and cytokine production during intravesical BCG therapy against this purified antigen 85 complex.Journal ArticleResearch Support, Non-U.S. Gov'tSCOPUS: ar.jinfo:eu-repo/semantics/publisheKeywords
This publication has 19 references indexed in Scilit:
- Prognostic Significance of Circulating Cytotoxic Lymphocytes Against Autologous Tumors in Patients With Bladder CancerJournal of Urology, 1996
- Urinary Cytokines During Intravesical Bacillus Calmetteguerin Therapy for Superficial Bladder Cancer: Processing, Stability and Prognostic ValueJournal of Urology, 1996
- The induction of bacillus-Calmette-Gu rin-activated killer cells requires the presence of monocytes and T-helper type-1 cellsCancer Immunology, Immunotherapy, 1995
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994
- Durability of the Tumor-Free Response for Intravesical Bacillus Calmette-Guerin TherapyJournal of Urology, 1994
- Immunity to mycobacteriaCurrent Opinion in Immunology, 1993
- Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.Journal of Clinical Investigation, 1990
- Specific Lymphoproliferation, Gamma Interferon Production, and Serum Immunoglobulin G Directed against a Purified 32 kDa Mycobacterial Protein Antigen (P32) in Patients with Active TuberculosisScandinavian Journal of Immunology, 1988
- Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin Viability on Treatment ResultsJournal of Urology, 1985
- Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.The Journal of Experimental Medicine, 1983